{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:21:08Z","timestamp":1788524468212,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"crossref","award":["43014245"],"award-info":[{"award-number":["43014245"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58610-y","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:16:16Z","timestamp":1781709376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of the insulinemic potential of diet and lifestyle with metabolic dysfunction-associated steatotic liver disease (MASLD) risk in adults with type 2 diabetes"],"prefix":"10.1038","volume":"16","author":[{"given":"Danial","family":"Fotros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieh","family":"Salavatizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ebrahim","family":"Khamseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Yari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"6","key":"58610_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78 (6), 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"58610_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.20517\/2394-5079.2023.134","volume":"10","author":"C Colaci","year":"2024","unstructured":"Colaci, C. et al. Dysmetabolic comorbidities and non-alcoholic fatty liver disease: A stairway to metabolic dysfunction-associated steatotic liver disease. Hepatoma Res. 10, 16 (2024).","journal-title":"Hepatoma Res."},{"issue":"2","key":"58610_CR3","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","volume":"80","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m, H., Vessby, J., Ekstedt, M. & Shang, Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J. Hepatol. 80 (2), e76\u2013e7 (2024).","journal-title":"J. Hepatol."},{"issue":"4","key":"58610_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology 77 (4), 1335\u20131347 (2023).","journal-title":"Hepatology"},{"issue":"1","key":"58610_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dsi23-0015","volume":"37","author":"K Cusi","year":"2024","unstructured":"Cusi, K. Nonalcoholic fatty liver disease in diabetes: A call to action. Diabetes Spectr. 37 (1), 5\u20137 (2024).","journal-title":"Diabetes Spectr."},{"issue":"3","key":"58610_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","volume":"78","author":"V Ajmera","year":"2023","unstructured":"Ajmera, V. et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J. Hepatol. 78 (3), 471\u2013478 (2023).","journal-title":"J. Hepatol."},{"issue":"2","key":"58610_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","volume":"44","author":"R Lomonaco","year":"2021","unstructured":"Lomonaco, R. et al. Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: The need for systematic screening. Diabetes Care. 44 (2), 399\u2013406 (2021).","journal-title":"Diabetes Care"},{"key":"58610_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/jcm11133649","volume":"11","author":"R Palma","year":"2022","unstructured":"Palma, R. et al. The role of insulin resistance in fueling NAFLD pathogenesis: From molecular mechanisms to clinical implications. J. Clin. Med. 11, 13 (2022).","journal-title":"J. Clin. Med."},{"issue":"1","key":"58610_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2337\/dsi23-0013","volume":"37","author":"JP Nogueira","year":"2024","unstructured":"Nogueira, J. P. & Cusi, K. Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: From bench to patient care. Diabetes Spectr. 37 (1), 20\u201328 (2024).","journal-title":"Diabetes Spectr."},{"issue":"4","key":"58610_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.livres.2023.11.006","volume":"7","author":"P Zou","year":"2023","unstructured":"Zou, P. & Wang, L. Dietary pattern and hepatic lipid metabolism. Liver Res. 7 (4), 275\u2013284 (2023).","journal-title":"Liver Res."},{"issue":"10","key":"58610_CR11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1017\/S0007114516003755","volume":"116","author":"FK Tabung","year":"2016","unstructured":"Tabung, F. K. et al. Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle. Br. J. Nutr. 116 (10), 1787\u20131798 (2016).","journal-title":"Br. J. Nutr."},{"issue":"2","key":"58610_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ajcn\/nqy093","volume":"108","author":"FK Tabung","year":"2018","unstructured":"Tabung, F. K. et al. Association of dietary insulinemic potential and colorectal cancer risk in men and women. Am. J. Clin. Nutr. 108 (2), 363\u2013370 (2018).","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"58610_CR13","doi-asserted-by":"publisher","first-page":"pky080","DOI":"10.1093\/jncics\/pky080","volume":"2","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. Association of the insulinemic potential of diet and lifestyle with risk of digestive system cancers in men and women. JNCI Cancer Spectr. 2 (4), pky080 (2018).","journal-title":"JNCI Cancer Spectr."},{"issue":"10","key":"58610_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1158\/1940-6207.CAPR-20-0236","volume":"13","author":"D Aroke","year":"2020","unstructured":"Aroke, D. et al. Inflammatory and insulinemic dietary patterns: Influence on circulating biomarkers and prostate cancer risk. Cancer Prev. Res. (Phila). 13 (10), 841\u2013852 (2020).","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"7","key":"58610_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/jch.14832","volume":"26","author":"N Seifi","year":"2024","unstructured":"Seifi, N. et al. The association of dietary indices for hyperinsulinemia and insulin resistance with the risk of metabolic syndrome: A population-based cross-sectional study. J. Clin. Hypertens. (Greenwich). 26 (7), 832\u2013841 (2024).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"5","key":"58610_CR16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/jn\/nxy319","volume":"149","author":"FK Tabung","year":"2019","unstructured":"Tabung, F. K., Satija, A., Fung, T. T., Clinton, S. K. & Giovannucci, E. L. Long-term change in both dietary insulinemic and inflammatory potential is associated with weight gain in adult women and men. J. Nutr. 149 (5), 804\u2013815 (2019).","journal-title":"J. Nutr."},{"key":"58610_CR17","doi-asserted-by":"publisher","first-page":"690428","DOI":"10.3389\/fnut.2021.690428","volume":"8","author":"N Shi","year":"2021","unstructured":"Shi, N. et al. Proinflammatory and hyperinsulinemic dietary patterns are associated with specific profiles of biomarkers predictive of chronic inflammation, glucose-insulin dysregulation, and dyslipidemia in postmenopausal women. Front. Nutr. 8, 690428 (2021).","journal-title":"Front. Nutr."},{"issue":"4","key":"58610_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.diabet.2018.10.001","volume":"45","author":"A Mantovani","year":"2019","unstructured":"Mantovani, A. et al. Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes Metab. 45 (4), 347\u2013355 (2019).","journal-title":"Diabetes Metab."},{"issue":"1","key":"58610_CR19","doi-asserted-by":"publisher","first-page":"8859338","DOI":"10.1155\/2021\/8859338","volume":"2021","author":"C Cai","year":"2021","unstructured":"Cai, C. et al. Transient elastography in alcoholic liver disease and nonalcoholic fatty liver disease: A systemic review and meta-analysis. Can. J. Gastroenterol. Hepatol. 2021 (1), 8859338 (2021).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"3","key":"58610_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen, A. et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137 (3), 865\u2013872 (2009).","journal-title":"Gastroenterology"},{"issue":"8","key":"58610_CR21","first-page":"1073","volume":"18","author":"MB Moghaddam","year":"2012","unstructured":"Moghaddam, M. B. et al. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: Content and construct validity, factor structure, internal consistency and stability. World Appl. Sci. J. 18 (8), 1073\u20131080 (2012).","journal-title":"World Appl. Sci. J."},{"issue":"6","key":"58610_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (6), 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"issue":"2","key":"58610_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2188\/jea.JE20090083","volume":"20","author":"FH Esfahani","year":"2010","unstructured":"Esfahani, F. H., Asghari, G., Mirmiran, P. & Azizi, F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J. Epidemiol. 20 (2), 150\u2013158 (2010).","journal-title":"J. Epidemiol."},{"issue":"213","key":"58610_CR24","first-page":"42","volume":"7","author":"M Ghaffarpour","year":"1999","unstructured":"Ghaffarpour, M., Houshiar-Rad, A. & Kianfar, H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran: Nashre Olume Keshavarzy. 7 (213), 42\u201358 (1999).","journal-title":"Tehran: Nashre Olume Keshavarzy"},{"issue":"10","key":"58610_CR25","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1017\/S0007114516003755","volume":"116","author":"FK Tabung","year":"2016","unstructured":"Tabung, F. K. et al. Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle. Br. J. Nutr. 116 (10), 1787\u20131798 (2016).","journal-title":"Br. J. Nutr."},{"issue":"5","key":"58610_CR26","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/jhn.12865","volume":"34","author":"MH Sohouli","year":"2021","unstructured":"Sohouli, M. H. et al. Association of dietary insulinaemic potential and odds of non-alcoholic fatty liver disease among adults: A case-control study. J. Hum. Nutr. Diet. 34 (5), 901\u2013909 (2021).","journal-title":"J. Hum. Nutr. Diet."},{"issue":"1","key":"58610_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40795-023-00675-3","volume":"9","author":"A Momeni","year":"2023","unstructured":"Momeni, A., Haghshenas, R. & Jahromi, S. R. The association of dietary and lifestyle indices for hyperinsulinemia with odds of non-alcoholic fatty liver disease in Iranian adults: A case-control study. BMC Nutr. 9 (1), 16 (2023).","journal-title":"BMC Nutr."},{"issue":"1","key":"58610_CR28","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1038\/s41598-025-88969-3","volume":"15","author":"A Nikparast","year":"2025","unstructured":"Nikparast, A. et al. Dietary and lifestyle indices for hyperinsulinemia and odds of MAFLD in overweight and obese children and adolescents. Sci. Rep. 15 (1), 4465 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"58610_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/liv.15057","volume":"42","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis. Liver Int. 42 (1), 69\u201379 (2022).","journal-title":"Liver Int."},{"issue":"7","key":"58610_CR30","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158 (7), 1999\u20132014 (2020). e1.","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"58610_CR31","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. 31 (Suppl), S32 (2024).","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"58610_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cell.2013.01.041","volume":"152","author":"MF Johnson Andrew","year":"2013","unstructured":"Johnson Andrew, M. F. & Olefsky Jerrold, M. The origins and drivers of insulin resistance. Cell 152 (4), 673\u2013684 (2013).","journal-title":"Cell"},{"key":"58610_CR33","doi-asserted-by":"publisher","first-page":"849031","DOI":"10.1155\/2014\/849031","volume":"2014","author":"M L\u00f3pez-Alarc\u00f3n","year":"2014","unstructured":"L\u00f3pez-Alarc\u00f3n, M. et al. Excessive refined carbohydrates and scarce micronutrients intakes increase inflammatory mediators and insulin resistance in prepubertal and pubertal obese children independently of obesity. Mediators Inflamm. 2014, 849031 (2014).","journal-title":"Mediators Inflamm."},{"issue":"6","key":"58610_CR34","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/dbi16-0010","volume":"65","author":"HA Ferris","year":"2016","unstructured":"Ferris, H. A. & Kahn, C. R. Unraveling the paradox of selective insulin resistance in the liver: The brain\u2013liver connection. Diabetes 65 (6), 1481\u20131483 (2016).","journal-title":"Diabetes"},{"issue":"25","key":"58610_CR35","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.3748\/wjg.v29.i25.3999","volume":"29","author":"SC Pal","year":"2023","unstructured":"Pal, S. C. & M\u00e9ndez-S\u00e1nchez, N. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World J. Gastroenterol. 29 (25), 3999\u20134008 (2023).","journal-title":"World J. Gastroenterol."},{"issue":"31","key":"58610_CR36","doi-asserted-by":"publisher","first-page":"11245","DOI":"10.1073\/pnas.0404297101","volume":"101","author":"G Chen","year":"2004","unstructured":"Chen, G., Liang, G., Ou, J., Goldstein, J. L. & Brown, M. S. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U S A. 101 (31), 11245\u201311250 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"58610_CR37","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1172\/JCI67227","volume":"123","author":"NB Ruderman","year":"2013","unstructured":"Ruderman, N. B., Carling, D., Prentki, M. & Cacicedo, J. M. AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Invest. 123 (7), 2764\u20132772 (2013).","journal-title":"J. Clin. Invest."},{"issue":"8","key":"58610_CR38","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 50 (8), 1844\u20131850 (2001).","journal-title":"Diabetes"},{"issue":"7","key":"58610_CR39","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","volume":"87","author":"A Sepp\u00e4l\u00e4-Lindroos","year":"2002","unstructured":"Sepp\u00e4l\u00e4-Lindroos, A. et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87 (7), 3023\u20133028 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"58610_CR40","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider, K. M. & Kahn, S. E. The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metabolism. 91 (12), 4753\u20134761 (2006).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"4","key":"58610_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo, R. A. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. diabetes 58 (4), 773\u2013795 (2009).","journal-title":"diabetes"},{"key":"58610_CR42","doi-asserted-by":"crossref","unstructured":"Wallace, T. M., Levy, J. C. & Matthews, D. R. Use and abuse of HOMA modeling. Diabetes Care-Alexandria Va. 27 (6), 1487\u20131495 (2004).","DOI":"10.2337\/diacare.27.6.1487"},{"issue":"9","key":"58610_CR43","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1172\/JCI34260","volume":"118","author":"S Schenk","year":"2008","unstructured":"Schenk, S., Saberi, M. & Olefsky, J. M. Insulin sensitivity: Modulation by nutrients and inflammation. J. Clin. Invest. 118 (9), 2992\u20133002 (2008).","journal-title":"J. Clin. Invest."},{"issue":"4","key":"58610_CR44","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung, U. J. & Choi, M. S. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 15 (4), 6184\u20136223 (2014).","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"58610_CR45","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.3390\/ijms21176358","volume":"21","author":"B Lair","year":"2020","unstructured":"Lair, B., Laurens, C., Van Den Bosch, B. & Moro, C. Novel insights and mechanisms of lipotoxicity-driven insulin resistance. Int. J. Mol. Sci. 21 (17), 6358 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"28","key":"58610_CR46","doi-asserted-by":"publisher","first-page":"16880","DOI":"10.1016\/S0021-9258(17)44844-7","volume":"265","author":"J Turinsky","year":"1990","unstructured":"Turinsky, J., O\u2019Sullivan, D. M. & Bayly, B. P. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J. Biol. Chem. 265 (28), 16880\u201316885 (1990).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"58610_CR47","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","volume":"51","author":"SI Itani","year":"2002","unstructured":"Itani, S. I., Ruderman, N. B., Schmieder, F. & Boden, G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51 (7), 2005\u20132011 (2002).","journal-title":"Diabetes"},{"issue":"52","key":"58610_CR48","doi-asserted-by":"publisher","first-page":"50230","DOI":"10.1074\/jbc.M200958200","volume":"277","author":"C Yu","year":"2002","unstructured":"Yu, C. et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (52), 50230\u201350236 (2002).","journal-title":"J. Biol. Chem."},{"key":"58610_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait, A. & den Hartigh, L. J. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front. Cardiovasc. Med. 7, 22 (2020).","journal-title":"Front. Cardiovasc. Med."},{"issue":"8","key":"58610_CR50","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.leu.2402197","volume":"15","author":"PP Ruvolo","year":"2001","unstructured":"Ruvolo, P. P. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia 15 (8), 1153\u20131160 (2001).","journal-title":"Leukemia"},{"key":"58610_CR51","doi-asserted-by":"crossref","unstructured":"Malik, A. N. et al. A Diet Induced maladaptive increase in hepatic mitochondrial DNA Precedes OXPHOS defects and may contribute to non-alcoholic fatty liver disease. Cells 8(10), 1222 (2019).","DOI":"10.3390\/cells8101222"},{"issue":"6","key":"58610_CR52","first-page":"494","volume":"2","author":"C Zhang","year":"2021","unstructured":"Zhang, C. & Yang, M. Molecular targets regulating endoplasmic reticulum-mitochondria crosstalk for NAFLD treatment. Explor. Med. 2 (6), 494\u2013510 (2021).","journal-title":"Explor. Med."},{"issue":"38","key":"58610_CR53","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","volume":"16","author":"G Tarantino","year":"2010","unstructured":"Tarantino, G., Savastano, S. & Colao, A. Hepatic steatosis, low-grade chronic inflammation and hormone\/growth factor\/adipokine imbalance. World J. Gastroenterol. 16 (38), 4773\u20134783 (2010).","journal-title":"World J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58610-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58610-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58610-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:03:02Z","timestamp":1788523382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58610-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58610"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58610-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Ethics Committee of the Shahid Beheshti University of Medical Sciences in accordance with the Declaration of Helsinki (Protocol No: IR.SBMU.NNFTRI.REC.1404.004).","order":2,"name":"Ethics","label":"<b>Ethical approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27731"}}